{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:02:34Z","timestamp":1789142554965,"version":"build-2803163510"},"reference-count":224,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The origins of photodynamic therapy (PDT) date back to 1904. Since then, the amount of research proving PDT and, consequently, its applicability to various disease states has steadily increased. Currently, PDT is mainly used in oncology to destroy cancer cells. It is being worked on for possible use in other medical fields as well, including cardiology. It can be used in the prevention of restenosis, often occurring after vascular surgical interventions, for destroying atherosclerotic plaques and as a new ablative method of ectopic centers in the treatment of atrial fibrillation. The purpose of this review is to summarize the knowledge to date regarding the therapeutic potential of using PDT for various pathological conditions in cardiology. The review also focuses on the current limitations associated with the use of PDT and identifies areas where more research is needed to develop better drug regimens. Materials and methods: The study analyzed 189 medical articles. The articles came from PubMed, Frontiers, Google Scholar, Science Direct and Web of Science databases. Through the excitation of light, a photosensitizer (PS) introduced into the body, the destruction of pathological cells occurs. PTD is widely used in oncology of the central nervous system (CNS). This process is made possible by the production of free oxygen radicals (ROS) and singlet oxygen, which generate oxidative stress that destroys sensitive cancer cells. In recent years, photosensitizers have also been discovered to have a strong affinity for macrophages that fill atherosclerotic plaques, making these compounds suitable for treating atherosclerosis. By inducing apoptosis of smooth muscle cells, inactivating basic fibroblast growth factor (FGF-\u03b2) and inhibiting endothelial cell hyperplasia, PDT can be used to prevent restenosis after surgical proceduresPDT appears to be a minimally invasive and highly effective therapeutic method, especially when combined with other therapeutic methods. Unfortunately, the small number of animal model studies and human clinical trials greatly limit the applicability of PDT on a wider scale. Current limitations, such as the depth of penetration, delivery of photosensitizer particles to the direct site of the lesion or the appropriate choice of photosensitizer in relation to the nature of the pathology, unfortunately make it impossible to replace current therapeutic approaches.<\/jats:p>","DOI":"10.3390\/ijms25063206","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T11:05:10Z","timestamp":1710155110000},"page":"3206","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Application of Photodynamic Therapy in Cardiology"],"prefix":"10.3390","volume":"25","author":[{"given":"Piotr","family":"Wa\u0144czura","sequence":"first","affiliation":[{"name":"Department of Cardiology, Medical College, The Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-6570","authenticated-orcid":false,"given":"David","family":"Aebisher","sequence":"additional","affiliation":[{"name":"Department of Photomedicine and Physical Chemistry, Medical College, The Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksymilian","family":"K\u0142osowicz","sequence":"additional","affiliation":[{"name":"English Division Science Club, Medical College, The Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0658-5471","authenticated-orcid":false,"given":"Angelika","family":"My\u015bliwiec","sequence":"additional","affiliation":[{"name":"Center for Innovative Research in Medical and Natural Sciences, Medical College, The Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6851-5869","authenticated-orcid":false,"given":"Klaudia","family":"Dynarowicz","sequence":"additional","affiliation":[{"name":"Center for Innovative Research in Medical and Natural Sciences, Medical College, The Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5557-5464","authenticated-orcid":false,"given":"Dorota","family":"Bartusik-Aebisher","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and General Chemistry, Medical College, The Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kessel, D. (2019). Photodynamic Therapy: A Brief History. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101581"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/tcr.201600121","article-title":"Photodynamic Therapy: Past, Present and Future","volume":"8","author":"Chilakamarthi","year":"2017","journal-title":"Chem. Rec."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e001926","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: Past, present and future","volume":"1","author":"Alzeibak","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40005-017-0377-x","article-title":"Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy","volume":"48","author":"Hwang","year":"2018","journal-title":"J. Pharm. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40257-017-0255-3","article-title":"The Role of Photodynamic Therapy in Acne: An Evidence-Based Review","volume":"3","author":"Boen","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1574891X113089990012","article-title":"Antimicrobial photodynamic therapy to kill Gram-negative bacteria","volume":"2","author":"Sperandio","year":"2013","journal-title":"Recent. Pat. Antiinfect. Drug Discov."},{"key":"ref_7","first-page":"e19500","article-title":"Treatment of herpes labialis by photodynamic therapy: Study protocol clinical trial (SPIRIT compliant)","volume":"12","author":"Negreiros","year":"2020","journal-title":"Medicine"},{"key":"ref_8","first-page":"1028","article-title":"Comparison of the efficacy of anti-VEGF monotherapy versus PDT and intravitreal anti-VEGF combination treatment in AMD: A Meta-analysis and systematic review","volume":"9","author":"Tong","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2147\/IJN.S355790","article-title":"Chemiexcited Photodynamic Therapy Integrated in Polymeric Nanoparticles Capable of MRI Against Atherosclerosis","volume":"17","author":"Mu","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_10","first-page":"65","article-title":"Inhibitory Effect of Photodynamic Therapy with Indocyanine Green on Rat Smooth Muscle Cells","volume":"35","author":"Lin","year":"2019","journal-title":"Acta Cardiol. Sin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/europace\/euv016","article-title":"Electrical superior vena cava isolation using photodynamic therapy in a canine model","volume":"18","author":"Kimura","year":"2016","journal-title":"Europace"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy\u2013mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10103-016-2110-9","article-title":"A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis","volume":"32","author":"Bhatta","year":"2017","journal-title":"Lasers Med. Sci."},{"key":"ref_14","first-page":"102","article-title":"Molecular mechanism of photodynamic therapy","volume":"39","author":"Chen","year":"2014","journal-title":"J. Cent. South Univ. Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Donohoe, C., Senge, M.O., Arnaut, L.G., and Gomes-da-Silva, L.C. (2019). Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity. Biochim. Biophys. Acta Rev. Cancer, 2.","DOI":"10.1016\/j.bbcan.2019.07.003"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s43046-021-00093-1","article-title":"Implications of photodynamic cancer therapy: An overview of PDT mechanisms basically and practically","volume":"33","author":"Sobhani","year":"2021","journal-title":"J. Egypt. Natl. Canc Inst."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1080\/15548627.2020.1783823","article-title":"Photodynamic therapy: Autophagy and mitophagy, apoptosis and paraptosis","volume":"11","author":"Kessel","year":"2020","journal-title":"Autophagy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/DSS.0000000000000800","article-title":"Photodynamic Therapy: A Clinical Consensus Guide","volume":"7","author":"Ozog","year":"2016","journal-title":"Dermatol. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/php.13209","article-title":"Photodynamic Therapy and the Biophysics of the Tumor Microenvironment","volume":"2","author":"Sorrin","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_20","first-page":"799","article-title":"Photodynamic Therapy as a Promising Method Used in the Treatment of Oral Diseases","volume":"4","author":"Mielczarek","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Alves, S.R., Calori, I.R., and Tedesco, A.C. (2021). Photosensitizer-based metal-organic frameworks for highly effective photodynamic therapy. Mater. Sci. Eng. C Mater. Biol. Appl., 131.","DOI":"10.1016\/j.msec.2021.112514"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102293","DOI":"10.1016\/j.pdpdt.2021.102293","article-title":"Effectiveness of photodynamic therapy with 5-aminolevulinic acid on HPV clearance in women without cervical lesions","volume":"34","author":"Cang","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mokoena, D.R., George, B.P., and Abrahamse, H. (2021). Photodynamic Therapy Induced Cell Death Mechanisms in Breast Cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms221910506"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.2147\/IJN.S269321","article-title":"Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles","volume":"15","author":"Hou","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/BJ20150942","article-title":"New photosensitizers for photodynamic therapy","volume":"4","author":"Abrahamse","year":"2016","journal-title":"Biochem. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"81591","DOI":"10.18632\/oncotarget.20189","article-title":"Porphyrin photosensitizers in photodynamic therapy and its applications","volume":"46","author":"Kou","year":"2017","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2217\/fon.13.176","article-title":"Photodynamic therapy: Oncologic horizons","volume":"1","author":"Allison","year":"2014","journal-title":"Future Oncol."},{"key":"ref_28","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"7","author":"Yang","year":"2020","journal-title":"Bioact. Mater."},{"key":"ref_29","first-page":"550","article-title":"Photodynamic Therapy and Immunity: An Update","volume":"3","author":"Gollnick","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102567","DOI":"10.1016\/j.pdpdt.2021.102567","article-title":"Organic light emitting diode for in vitro antimicrobial photodynamic therapy of Candida strains","volume":"36","author":"Persheyev","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pdpdt.2018.10.023","article-title":"Photodynamic therapy in the treatment of oral leukoplakia: A systematic review","volume":"25","author":"Li","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.breast.2016.09.016","article-title":"Photodynamic therapy: Inception to application in breast cancer","volume":"31","author":"Banerjee","year":"2017","journal-title":"Breast"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: An update","volume":"4","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.det.2014.03.009","article-title":"Photodynamic therapy","volume":"3","author":"Rkein","year":"2014","journal-title":"Dermatol. Clin."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pdpdt.2015.07.177","article-title":"Quinones as photosensitizer for photodynamic therapy: ROS generation, mechanism and detection methods","volume":"13","author":"Rajendran","year":"2016","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/S0140-6736(21)00684-X","article-title":"The Lancet women and cardiovascular disease Commission: Reducing the global burden by 2030","volume":"397","author":"Vogel","year":"2021","journal-title":"Lancet"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease","volume":"4","author":"Herrington","year":"2016","journal-title":"Circ. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.308334","article-title":"Atherosclerosis: Successes, Surprises, and Future Challenges","volume":"118","author":"Libby","year":"2016","journal-title":"Circ. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.118.313816","article-title":"Atherosclerosis","volume":"10","author":"Kobiyama","year":"2018","journal-title":"Circ. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1749-6632.2000.tb06318.x","article-title":"Endothelial dysfunction, hemodynamic forces, and atherogenesis","volume":"902","author":"Gimbrone","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/CIRCRESAHA.111.263186","article-title":"Lymphocytes and the adventitial immune response in atherosclerosis","volume":"110","author":"Campbell","year":"2012","journal-title":"Circ. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Chapman","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: From plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","article-title":"How common is residual inflammatory risk?","volume":"120","author":"Ridker","year":"2017","journal-title":"Circ. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MCA.0000000000000844","article-title":"Unplanned hospital readmissions after acute myocardial infarction: A nationwide analysis of rates, trends, predictors and causes in the United States between 2010 and 2014","volume":"31","author":"Kwok","year":"2020","journal-title":"Coron. Artery Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41569-019-0202-5","article-title":"70-year legacy of the Framingham Heart Study","volume":"16","author":"Andersson","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.120.315928","article-title":"Polygenic scores to assess atherosclerotic cardiovascular disease risk","volume":"126","author":"Aragam","year":"2020","journal-title":"Circ. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jama.2019.22241","article-title":"Predictive accuracy of a polygenic risk score-enhanced prediction model vs a clinical risk score for coronary artery disease","volume":"323","author":"Elliott","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2019.21782","article-title":"Predictive accuracy of a polygenic risk score compared with a clinical risk score for incident coronary heart disease","volume":"323","author":"Mosley","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/CIRCULATIONAHA.118.038571","article-title":"Caveolin-1 regulates atherogenesis by attenuating low-density lipoprotein transcytosis and vascular inflammation independently of endothelial nitric oxide synthase activation","volume":"140","author":"Zhang","year":"2019","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jacc.2011.12.033","article-title":"Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction","volume":"59","author":"Leibundgut","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.01.023","article-title":"Counterregulation rules in atherothrombosis","volume":"59","author":"Libby","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00041433-200210000-00003","article-title":"Sequestration of aggregated low-density lipoproteins by macrophages","volume":"13","author":"Kruth","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI63108","article-title":"Adaptive immunity in atherogenesis: New insights and therapeutic approaches","volume":"123","author":"Lichtman","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Hansson","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI29950","article-title":"Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata","volume":"117","author":"Swirski","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cvr\/cvy007","article-title":"Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis","volume":"114","author":"Grootaert","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"118397","DOI":"10.1016\/j.lfs.2020.118397","article-title":"Bazedoxifene inhibits PDGF-BB induced VSMC phenotypic switch via regulating the autophagy level","volume":"259","author":"Song","year":"2020","journal-title":"Life Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","article-title":"Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis","volume":"129","author":"Allahverdian","year":"2014","journal-title":"Circulation"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0040-8166(87)90072-3","article-title":"Identification of smooth muscle-derived foam cells in the atherosclerotic plaque of human aorta with monoclonal antibody IIG10","volume":"19","author":"Glukhova","year":"1987","journal-title":"Tissue Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.ATV.10.5.680","article-title":"Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits","volume":"10","author":"Rosenfeld","year":"1990","journal-title":"Arteriosclerosis"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Gerasymchuk, Y., Ka\u0142as, W., Arkowski, J., Marciniak, \u0141., Hreniak, D., Wysoki\u0144ska, E., Strz\u0105da\u0142a, L., Obremska, M., Tomachynski, L., and Chernii, V. (2021). Gallato Zirconium (IV) Phtalocyanine Complex Conjugated with SiO2 Nanocarrier as a Photoactive Drug for Photodynamic Therapy of Atheromatic Plaque. Molecules, 26.","DOI":"10.3390\/molecules26020260"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pdpdt.2018.12.002","article-title":"Pyropheophorbide-alpha methyl ester-mediated photodynamic therapy induces apoptosis and inhibits LPS-induced inflammation in RAW7 macrophages","volume":"25","author":"Huang","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e12238","DOI":"10.1111\/1755-5922.12238","article-title":"Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation?","volume":"2","author":"Jain","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejps.2017.06.038","article-title":"Macrophage selective photodynamic therapy by meta-tetra(hydroxyphenyl)chlorin loaded polymeric micelles: A possible treatment for cardiovascular diseases","volume":"107","author":"Wennink","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Ka\u0142as, W., Wysoki\u0144ska, E., Przyby\u0142o, M., Langner, M., Ulatowska-Jar\u017ca, A., Bia\u0142y, D., Wawrzy\u0144ska, M., Zio\u0142o, E., Gil, W., and Trzeciak, A.M. (2019). Photoactive Liposomal Formulation of PVP-Conjugated Chlorin e6 for Photodynamic Reduction of Atherosclerotic Plaque. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163852"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fphys.2016.00400","article-title":"Intra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne\u00ae: Implication for Atherosclerotic Plaque Treatment","volume":"7","author":"Jain","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.bbamcr.2007.04.015","article-title":"Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity","volume":"1773","author":"Zhang","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0014-2999(92)90727-L","article-title":"Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation","volume":"221","author":"Huang","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1745-7254.2008.00783.x","article-title":"Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1\/caveolin-1 signaling pathway in vascular smooth muscle cells","volume":"29","author":"Yuan","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Gu, H., Li, H., Tang, Y., Zheng, X.L., and Liao, D.F. (2016). Nicotinate-curcumin impedes foam cell formation from THP-1 cells through restoring autophagy flux. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154820"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coph.2018.01.013","article-title":"Invasive treatment in peripheral artery disease","volume":"39","author":"Deftereos","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/CIRCULATIONAHA.119.044467","article-title":"Exercise and Coronary Atherosclerosis: Observations, Explanations, Relevance, and Clinical Management","volume":"141","author":"Aengevaeren","year":"2020","journal-title":"Circulation"},{"key":"ref_83","unstructured":"Omeh, D.J., and Shlofmitz, E. (2022). StatPearls."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.2174\/0929867321666131218095802","article-title":"Indocyanine green: Photosensitizer or chromophore? Still a debate","volume":"21","author":"Giraudeau","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e2864","DOI":"10.1038\/cddis.2017.242","article-title":"Upconversion nanoparticle-mediated photodynamic therapy induces autophagy and cholesterol efflux of macrophage-derived foam cells via ROS generation","volume":"8","author":"Han","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/FJC.0000000000001069","article-title":"Curcumin-mediated Photodynamic Therapy Inhibits the Phenotypic Transformation, Migration, and Foaming of Oxidized Low-density Lipoprotein-treated Vascular Smooth Muscle Cells by Promoting Autophagy","volume":"78","author":"Wang","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Koirala, D., Beranova-Giorgianni, S., and Giorgianni, F. (2020). Early transcriptomic response to OxLDL in human retinal pigment epithelial cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228818"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/jcmm.16106","article-title":"Acacetin exerts antioxidant potential against atherosclerosis through Nrf2 pathway in apoE Mice","volume":"25","author":"Wu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00441-020-03338-y","article-title":"Suppression of miR-4463 promotes phenotypic switching in VSMCs treated with Ox-LDL","volume":"383","author":"Wang","year":"2020","journal-title":"Cell Tissue Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1111\/jcmm.14401","article-title":"SCD1 activation impedes foam cell formation by inducing lipophagy in oxLDL-treated human vascular smooth muscle cells","volume":"23","author":"Pi","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/cells1030464","article-title":"Autophagy contributes to the death\/survival balance in cancer PhotoDynamic therapy","volume":"1","author":"Inguscio","year":"2012","journal-title":"Cells"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1080\/15548627.2015.1078960","article-title":"Autophagic death probed by photodynamic therapy","volume":"11","author":"Kessel","year":"2015","journal-title":"Autophagy"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jacc.2008.06.023","article-title":"PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression","volume":"52","author":"Waksman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(17)31927-X","article-title":"Coronary balloon angioplasty, stents, and scaffolds","volume":"390","author":"Byrne","year":"2017","journal-title":"Lancet"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Stevens, J.R., Zamani, A., Osborne, J.I.A., Zamani, R., and Akrami, M. (2021). Critical evaluation of stents in coronary angioplasty: A systematic review. Biomed. Eng. Online, 20.","DOI":"10.1186\/s12938-021-00883-7"},{"key":"ref_96","first-page":"i205","article-title":"What is the role of coronary angioplasty and stenting in stable angina?","volume":"352","author":"Davies","year":"2016","journal-title":"BMJ"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2017.1.FOCUS16507","article-title":"Stent technology in ischemic stroke","volume":"42","author":"Yoon","year":"2017","journal-title":"Neurosurg. Focus."},{"key":"ref_98","first-page":"637","article-title":"Coronary In-Stent Restenosis: Predictors and Treatment","volume":"118","author":"Ullrich","year":"2021","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11886-018-0952-4","article-title":"Therapeutic Options for In-Stent Restenosis","volume":"20","author":"Nicolais","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12933-022-01460-5","article-title":"Diabetes and restenosis","volume":"21","author":"Wilson","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14779072.2017.1284588","article-title":"Treatment of coronary artery in-stent restenosis","volume":"15","author":"Kokkinidis","year":"2017","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.carrev.2020.09.045","article-title":"In-Stent Restenosis: Burn and Rebuild?","volume":"22","author":"Aoki","year":"2021","journal-title":"Cardiovasc. Revasc Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiology.218.3.r01mr38711","article-title":"Brachial arterial access: Endovascular treatment of failing Brescia-Cimino hemodialysis fistulas\u2013initial success and long-term results","volume":"218","author":"Manninen","year":"2001","journal-title":"Radiology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1046\/j.1523-1755.2000.00940.x","article-title":"Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology","volume":"57","author":"Pengloan","year":"2000","journal-title":"Kidney Int."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1051-0443(07)60009-8","article-title":"Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas","volume":"13","author":"Clark","year":"2002","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/01.RVI.0000183588.57568.36","article-title":"Prospective study of balloon inflation pressures and other technical aspects of hemodialysis access angioplasty","volume":"16","author":"Trerotola","year":"2005","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.RVI.0000208988.28121.AB","article-title":"Angioplasty balloon inflation pressures during treatment of hemodialysis graft-related stenoses","volume":"17","author":"Vesely","year":"2006","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/hdi.12183","article-title":"Dialysis access venous stenosis: Treatment with balloon angioplasty 30-second vs. 1-minute inflation times","volume":"19","author":"Elramah","year":"2015","journal-title":"Hemodial. Int."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1148\/radiol.2491071845","article-title":"Dialysis access venous stenoses: Treatment with balloon angioplasty\u20141-versus 3-minute inflation times","volume":"249","author":"Forauer","year":"2008","journal-title":"Radiology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1097\/01.RVI.0000094618.61428.58","article-title":"Society of Interventional Radiology Technology Assessment C. Reporting standards for percutaneous interventions in dialysis access","volume":"14","author":"Gray","year":"2003","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.tvir.2008.09.002","article-title":"Clinical surveillance and monitoring of arteriovenous access for hemodialysis","volume":"11","author":"Gelbfish","year":"2008","journal-title":"Tech. Vasc. Interv. Radiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.CIR.98.1.82","article-title":"Cell cycle progression: New therapeutic target for vascular proliferative disease","volume":"98","author":"Mann","year":"1998","journal-title":"Circulation"},{"key":"ref_113","first-page":"10","article-title":"Comparison of clinical outcomes in patients undergoing coronary intervention with drug-eluting stents or bare-metal stents: A nationwide population study","volume":"33","author":"Sung","year":"2017","journal-title":"Acta Cardiol. Sin."},{"key":"ref_114","first-page":"570","article-title":"Frequency of vascular inflammation and impact on neointimal proliferation of drug eluting stents in porcine coronary arteries","volume":"32","author":"Yeh","year":"2016","journal-title":"Acta Cardiol. Sin."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0735-1097(10)80196-2","article-title":"A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies","volume":"17","author":"Forrester","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/01.ATV.0000037100.44766.5B","article-title":"Inflammation and restenosis in the stent era","volume":"22","author":"Welt","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"101891","DOI":"10.1016\/j.pdpdt.2020.101891","article-title":"The effect of indocyanine green-based photodynamic therapy on healthy fibroblast and keratinocyte cells","volume":"31","author":"Onak","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Suzuki, T., Tanaka, M., Sasaki, M., Ichikawa, H., Nishie, H., and Kataoka, H. (2020). Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium. Cancers, 12.","DOI":"10.3390\/cancers12092369"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"101568","DOI":"10.1016\/j.pdpdt.2019.10.003","article-title":"Photodynamic therapy for atherosclerosis. The potential of indocyanine green","volume":"29","author":"Houthoofd","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10103-018-2488-7","article-title":"Photodynamic therapy of balloon-injured rat carotid arteries using indocyanine green","volume":"33","author":"Lin","year":"2018","journal-title":"Lasers Med. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e001472","DOI":"10.1161\/JAHA.114.001472","article-title":"Local association between endothelial dysfunction and intimal hyperplasia: Relevance in peripheral artery disease","volume":"4","author":"Heinen","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2016.06.046","article-title":"Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis","volume":"251","author":"Krishnan","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_123","first-page":"508","article-title":"In-stent restenosis management: The best is yet to come","volume":"58","year":"2017","journal-title":"J. Cardiovasc. Surg."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.biopha.2016.07.058","article-title":"The potential of photodynamic therapy (PDT)-Experimental investigations and clinical use","volume":"83","author":"Oniszczuk","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"ITC33","DOI":"10.7326\/AITC201703070","article-title":"Atrial Fibrillation","volume":"166","author":"Zimetbaum","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Tonko, J.B., and Wright, M.J. (2021). Review of the 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation-What Has Changed and How Does This Affect Daily Practice. J. Clin. Med., 10.","DOI":"10.3390\/jcm10173922"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_129","first-page":"213","article-title":"Epidemiology of atrial fibrillation: European perspective","volume":"6","author":"Lercari","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/STROKEAHA.113.002329","article-title":"Atrial fibrillation, stroke risk, and warfarin therapy revisited: A population-based study","volume":"44","author":"Bjorck","year":"2013","journal-title":"Stroke"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"001486","DOI":"10.1161\/JAHA.114.001486","article-title":"Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with in-cident non-valvular atrial fibrillation","volume":"4","author":"Haim","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1161\/CIRCULATIONAHA.112.129759","article-title":"An update on the prognosis of patients with atrial fibrillation","volume":"126","author":"McManus","year":"2012","journal-title":"Circulation"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","article-title":"Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century","volume":"167","author":"Ball","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.ijcard.2013.01.184","article-title":"Review of epidemiology and management of atrial fibrillation in developing countries","volume":"167","author":"Nguyen","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.113.005451","article-title":"RE-LY Atrial Fibrillation Registry Investigators. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: The RE-LY Atrial Fibrillation Registry","volume":"129","author":"Oldgren","year":"2014","journal-title":"Circulation"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: Insight from the real-life global survey evaluating patients with atrial fibrillation international registry","volume":"5","author":"Chiang","year":"2012","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/STROKEAHA.113.003433","article-title":"Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: A systematic review and meta-analysis","volume":"45","author":"Kishore","year":"2014","journal-title":"Stroke"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: The Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehs469","article-title":"All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995\u20132008: A Swedish nationwide long-term case-control study","volume":"34","author":"Andersson","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: Relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/pace.13777","article-title":"Pathophysiology of atrial fibrillation: Focal patterns of activation","volume":"42","author":"Allessie","year":"2019","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.19102\/icrm.2017.080406","article-title":"The Role of Superior Vena Cava Isolation in the Management of Atrial Fibrillation","volume":"8","author":"Goyal","year":"2017","journal-title":"J. Innov. Card. Rhythm. Manag."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Silva, Z.S., Bussadori, S.K., Fernandes, K.P., Huang, Y.Y., and Hamblin, M.R. (2015). Animal models for photodynamic therapy (PDT). Biosci. Rep., 35.","DOI":"10.1042\/BSR20150188"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/CIRCEP.113.000810","article-title":"Nonthermal cardiac catheter ablation using photodynamic therapy","volume":"6","author":"Kimura","year":"2013","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.7150\/thno.16183","article-title":"Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy","volume":"6","author":"Mallidi","year":"2016","journal-title":"Theranostics"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/php.13155","article-title":"Predictors and Limitations of the Penetration Depth of Photodynamic Effects in the Rodent Brain","volume":"96","author":"Inglut","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10555-015-9588-7","article-title":"Tumor cell survival pathways activated by photodynamic therapy: A molecular basis for pharmacological inhibition strategies","volume":"34","author":"Broekgaarden","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cbin.11137","article-title":"Cell death: A review of the major forms of apoptosis, necrosis and autophagy","volume":"43","year":"2019","journal-title":"Cell Biol. Int."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"14066","DOI":"10.1002\/anie.201814098","article-title":"Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors","volume":"58","author":"Yang","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Niculescu, A.-G., and Grumezescu, A.M. (2021). Photodynamic Therapy\u2014An Up-to-Date Review. Appl. Sci., 11.","DOI":"10.3390\/app11083626"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7150\/thno.9476","article-title":"Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases","volume":"5","author":"Patel","year":"2015","journal-title":"Theranostics"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/1522-2594(200012)44:6<867::AID-MRM7>3.0.CO;2-P","article-title":"High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent","volume":"44","author":"Yu","year":"2000","journal-title":"Magn. Reson. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/hc3601.094303","article-title":"Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques","volume":"104","author":"Flacke","year":"2001","journal-title":"Circulation"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.CIR.103.3.415","article-title":"Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits","volume":"103","author":"Ruehm","year":"2001","journal-title":"Circulation"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"275ra20","DOI":"10.1126\/scitranslmed.aaa1065","article-title":"Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice","volume":"7","author":"Fredman","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41596-021-00665-4","article-title":"Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages","volume":"17","author":"Huang","year":"2022","journal-title":"Nat. Protoc."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1021\/acsnano.6b01114","article-title":"Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis","volume":"10","author":"Kamaly","year":"2016","journal-title":"ACS Nano"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.113.002870","article-title":"Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization\/rupture in mice by regulating the recruitment of inflammatory monocytes","volume":"129","author":"Katsuki","year":"2014","journal-title":"Circulation"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/ATVBAHA.115.307057","article-title":"Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte\/Macrophage Differentiation in ApoE\u2212\/\u2212 Mice","volume":"36","author":"Nakashiro","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nano.2018.08.002","article-title":"Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE\u2212\/\u2212) mice","volume":"15","author":"Song","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"eaay1063","DOI":"10.1126\/scitranslmed.aay1063","article-title":"siRNA nanoparticles targeting CaMKII\u03b3 in lesional macrophages improve atherosclerotic plaque stability in mice","volume":"12","author":"Tao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Kim, M., Sahu, A., Hwang, Y., Kim, G.B., Nam, G.H., Kim, I.S., Chan Kwon, I., and Tae, G. (2020). Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E\u2212\/\u2212 mice. Biomaterials, 226.","DOI":"10.1016\/j.biomaterials.2019.119550"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1900172","DOI":"10.1002\/advs.201900172","article-title":"Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management","volume":"6","author":"Wang","year":"2019","journal-title":"Adv. Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1002\/anie.201913700","article-title":"Molecularly Engineered Macrophage-Derived Exosomes with Inflammation Tropism and Intrinsic Heme Biosynthesis for Atherosclerosis Treatment","volume":"10","author":"Wu","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jconrel.2020.11.064","article-title":"Platelet-derived extracellular vesicles to target plaque inflammation for effective anti-atherosclerotic therapy","volume":"329","author":"Ma","year":"2021","journal-title":"J. Control Release"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2017.07.013","article-title":"A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis","volume":"262","author":"Alaarg","year":"2017","journal-title":"J. Control Release"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"eaaw7736","DOI":"10.1126\/scitranslmed.aaw7736","article-title":"Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species","volume":"11","author":"Binderup","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41551-018-0221-2","article-title":"Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates","volume":"2","author":"Lameijer","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"E6731","DOI":"10.1073\/pnas.1609629113","article-title":"Immune cell screening of a nanoparticle library improves atherosclerosis therapy","volume":"113","author":"Tang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jcmg.2016.01.020","article-title":"In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models","volume":"9","author":"Binderup","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jacc.2017.11.055","article-title":"Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis","volume":"71","author":"Seijkens","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e1400223","DOI":"10.1126\/sciadv.1400223","article-title":"Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation","volume":"1","author":"Tang","year":"2015","journal-title":"Sci. Adv."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1038\/ncomms4065","article-title":"A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation","volume":"5","author":"Duivenvoorden","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2017.12.021","article-title":"Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression","volume":"28","author":"Guo","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2016.05.038","article-title":"HDL mimetic CER-001 targets atherosclerotic plaques in patients","volume":"251","author":"Zheng","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_184","first-page":"689360","article-title":"The renin-angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int. J. Inflamm."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: An update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Bharadwaj, D., Prasad, G., Grechko, A.V., Sazonova, M.A., and Orekhov, A.N. (2021). Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136702"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.atherosclerosis.2015.02.055","article-title":"Comparison of angiotensin-(1\u20137), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice","volume":"240","author":"Yang","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/ATVBAHA.113.301320","article-title":"Angiotensin-(1\u20137) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells","volume":"33","author":"Yang","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_189","first-page":"77","article-title":"Angiotensin-(1\u20137) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice","volume":"63","author":"Jawien","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"BR389","DOI":"10.12659\/MSM.883478","article-title":"The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis","volume":"18","author":"Jawien","year":"2012","journal-title":"Med. Sci. Monit."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/CS20130436","article-title":"Angiotensin-(1\u20137) and angiotensin-(1\u20139): Function in cardiac and vascular remodelling","volume":"126","author":"McKinney","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"11903","DOI":"10.1038\/s41598-017-12074-3","article-title":"Ang-(1\u20137) is an endogenous \u03b2-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy","volume":"7","author":"Teixeira","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_193","first-page":"561","article-title":"Photodynamic combinational therapy in cancer treatment","volume":"23","author":"Zhang","year":"2018","journal-title":"J. Buon"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"691697","DOI":"10.3389\/fchem.2021.691697","article-title":"Photodynamic Therapy-Current Limitations and Novel Approaches","volume":"9","author":"Gunaydin","year":"2021","journal-title":"Front. Chem."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Park, J., Lee, Y.-K., Park, I.-K., and Hwang, S.R. (2021). Current Limitations and Recent Progress in Nanomedicine for Clinically Available Photodynamic Therapy. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010085"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7150\/thno.67300","article-title":"Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy","volume":"12","author":"Ji","year":"2022","journal-title":"Theranostics"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2018.10.042","article-title":"Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma","volume":"80","author":"Keyal","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/php.13223","article-title":"Techniques to Improve Photodynamic Therapy","volume":"96","author":"Roberts","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1172\/JCI110782","article-title":"Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative","volume":"71","author":"Spears","year":"1983","journal-title":"J. Clin. Investig."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0735-1097(86)80312-6","article-title":"Uptake of hematoporphyrin derivative by atheromatous plaques: Studies in human in vitro and rabbit in vivo","volume":"8","author":"Spokojny","year":"1986","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1253\/jcj.63.387","article-title":"Photodynamic therapy for the prevention of intimal hyperplasia in balloon-injured rabbit arteries","volume":"63","author":"Usui","year":"1999","journal-title":"Jpn. Circ. J."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1583\/1074-6218(1995)002<0365:DLDFPT>2.0.CO;2","article-title":"Determining light dose for photodynamic therapy of atherosclerotic lesions in the Yucatan miniswine","volume":"2","author":"Hsiang","year":"1995","journal-title":"J. Endovasc. Surg."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jphotobiol.2003.10.004","article-title":"Longer term assessment of photodynamic therapy for intimal hyperplasia: A pilot study","volume":"73","author":"Cheung","year":"2004","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1751-1097.1993.tb02329.x","article-title":"Determining the optimal dose of Photofrin in miniswine atherosclerotic plaque","volume":"57","author":"Hsiang","year":"1993","journal-title":"Photochem. Photobiol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/lsm.20018","article-title":"A first trial in the clinical application of photodynamic therapy for the prevention of restenosis after coronary-stent placement","volume":"34","author":"Usui","year":"2004","journal-title":"Lasers Surg. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jphotobiol.2010.09.001","article-title":"Detection and photodynamic therapy of inflamed atherosclerotic plaques in the carotid artery of rabbits","volume":"102","author":"Peng","year":"2011","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejvs.2005.07.003","article-title":"Inhibition of in-stent restenosis in rabbit iliac arteries with photodynamic therapy","volume":"30","author":"Pai","year":"2005","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0008-6363(99)00352-1","article-title":"Reduction in the response to coronary and iliac artery injury with photodynamic therapy using 5-aminolaevulinic acid","volume":"45","author":"Jenkins","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1078-5884(98)80047-6","article-title":"Intra-arterial photodynamic therapy using 5-ALA in a swine model","volume":"16","author":"Jenkins","year":"1998","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1751-1097.2008.00325.x","article-title":"Fluorescence kinetics of protoporphyrin-IX induced from 5-ALA compounds in rabbit postballoon injury model for ALA-photoangioplasty","volume":"84","author":"Kwon","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.CIR.85.3.1189","article-title":"Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia","volume":"85","author":"Ortu","year":"1992","journal-title":"Circulation"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1751-1097.1998.tb05207.x","article-title":"Importance of the treatment field for the application of vascular photodynamic therapy to inhibit intimal hyperplasia","volume":"67","author":"ChandraSekar","year":"1998","journal-title":"Photochem. Photobiol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0741-5214(94)70107-5","article-title":"Photodynamic therapy inhibition of experimental intimal hyperplasia: Acute and chronic effects","volume":"19","author":"LaMuraglia","year":"1994","journal-title":"J. Vasc. Surg."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1078-5884(96)80130-4","article-title":"Inhibition of intimal hyperplasia in balloon injured arteries with adjunctive phthalocyanine sensitised photodynamic therapy","volume":"11","author":"Nyamekye","year":"1996","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/lsm.1066","article-title":"Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries","volume":"28","author":"Nagae","year":"2001","journal-title":"Lasers Surg. Med."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1155\/DTE.5.191","article-title":"Photodynamic diagnosis and treatment for atherosclerosis by an endoscopic approach","volume":"5","author":"Hayashi","year":"1999","journal-title":"Diagn. Ther. Endosc."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00795-005-0301-8","article-title":"Long-term inhibition of intimal hyperplasia using vascular photodynamic therapy in balloon-injured carotid arteries","volume":"38","author":"Wakamatsu","year":"2005","journal-title":"Med. Mol. Morphol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1751-1097.1993.tb02935.x","article-title":"In vitro and in vivo uptake of benzoporphyrin derivative into human and miniswine atherosclerotic plaque","volume":"57","author":"Hsiang","year":"1993","journal-title":"Photochem. Photobiol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1096-9101(1998)23:5<263::AID-LSM6>3.0.CO;2-V","article-title":"Photodynamic therapy with local photosensitizer delivery inhibits experimental intimal hyperplasia","volume":"23","author":"Adili","year":"1998","journal-title":"Lasers Surg. Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0008-6363(00)00278-9","article-title":"Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model","volume":"49","author":"Hayase","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"III275","DOI":"10.1161\/circ.102.suppl_3.III-275","article-title":"Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model","volume":"102","author":"Yamaguchi","year":"2000","journal-title":"Circulation"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/clm.1996.14.343","article-title":"Phototherapy of cancer and atheromatous plaque with texaphyrins","volume":"14","author":"Woodburn","year":"1996","journal-title":"J. Clin. Laser Med. Surg."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.CIR.102.5.591","article-title":"Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy","volume":"102","author":"Rockson","year":"2000","journal-title":"Circulation"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1751-1097.1997.tb01938.x","article-title":"Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits","volume":"65","author":"Allison","year":"1997","journal-title":"Photochem. Photobiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/6\/3206\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:12:03Z","timestamp":1760105523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/6\/3206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":224,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ijms25063206"],"URL":"https:\/\/doi.org\/10.3390\/ijms25063206","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]}}}